Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Cancer ; 73(2): 339-349, 2021.
Article in English | MEDLINE | ID: mdl-32475178

ABSTRACT

Increased risk of pancreatic cancer may be associated with consumption of sugar containing foods. The aim of this study was to evaluate the effect of peach nectar containing high fructose corn sirup (HFCS) consumption in a pancreatic carcinogenesis rat model induced by 7,12-Dimethyl benzanthracene (DMBA). Fifty-day-old male Sprague Dawley rats were fed with peach nectar containing HFCS + chow, peach nectar containing sucrose + chow and only chow. After 8 mo, feeding period, each group was divided into two subgroups, in which the rats were implanted with DMBA and no DMBA (sham). Histologic specimens were evaluated according to the routine tissue processing protocol. The animals with ad libitum access to pn-HFCS, pn-sucrose and chow (only) showed significant differences in chow consumption and glucose level. Necropsy and histopathologic findings showed tumor formation in the entire group treated with DMBA. Excluding one rat in chow group, which was classified as poorly differentiated type, the others were classified as moderately differentiated pancreatic ductal adenocarcinoma (PDAC). This study demonstrated that daily intake of HFCS did not increase body weight and there was no effect of peach nectar consumption on the development of PDAC induced by DMBA in rats.


Subject(s)
Carcinoma, Pancreatic Ductal , High Fructose Corn Syrup , Pancreatic Neoplasms , 9,10-Dimethyl-1,2-benzanthracene/toxicity , Animals , Carcinoma, Pancreatic Ductal/chemically induced , Fructose , Male , Pancreatic Neoplasms/chemically induced , Rats , Rats, Sprague-Dawley , Zea mays
2.
J Clin Res Pediatr Endocrinol ; 3(4): 212-5, 2011.
Article in English | MEDLINE | ID: mdl-22155465

ABSTRACT

Myasthenia gravis (MG) is an autoimmune disorder characterized by autoantibodies against acetylcholine receptors. MG is generally an isolated disorder but may occur concomitantly with other autoimmune diseases. We describe an eighteen-year-old girl with MG who was admitted to our clinic with secondary amenorrhea and diagnosed as autoimmune oophoritis. Since her myasthenic symptoms did not resolve with anticholinesterase therapy, thymectomy was performed. After thymectomy, her menses have been regular without any hormonal replacement therapy. To our knowledge, this is the first report on a patient with autoimmune ovarian insufficiency and MG in whom premature ovarian insufficiency resolved after thymectomy, without hormonal therapy.


Subject(s)
Myasthenia Gravis/complications , Oophoritis/surgery , Polyendocrinopathies, Autoimmune/surgery , Primary Ovarian Insufficiency/surgery , Thymectomy , Amenorrhea/complications , Bipolar Disorder/chemically induced , Female , Humans , Myasthenia Gravis/surgery , Oophoritis/complications , Ovarian Cysts/etiology , Ovarian Cysts/surgery , Ovarian Diseases/surgery , Polyendocrinopathies, Autoimmune/complications , Prednisolone/adverse effects , Primary Ovarian Insufficiency/etiology
3.
Pediatr Allergy Immunol ; 19(8): 773-6, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18221460

ABSTRACT

Inhaled corticosteroids (ICS) are preferred drugs for the long-term treatment of all severities of asthma in children. However, data about the safety of ICS in infants is lacking. So, it is essential to do further clinical studies to examine the safety and efficacy of ICS in this population. In this study, the effects of nebulized budesonide and nebulized fluticasone propionate suspensions on hypothalamic-pituitary-adrenal axis is examined in infants with recurrent or persistent wheeze. Thirty-one children aged 6-24 months admitted to our hospital between January and December 2005 with symptoms of recurrent or persistent wheeze were included in the study. The patients were randomly allocated to receive 0.25 mg BUD or 0.25 mg fluticasone propionate twice daily for 6 wk and half dose for another 6 wk with a jet nebulizer at home. Blood samples for basal cortisol concentration, adrenocarticotropic hormone, glucose, HbA1c and electrolytes were obtained at the beginning and at the end of the study. Adrenal function assessment was based on changes in cosyntropin-stimulated plasma cortisol levels. The study was completed with 31 patients, 16 of whom received BUD and 15 FP. All patients except one had plasma cortisol concentrations above 500 nmol/l (18 microg/dl) or had an incremental rise in cortisol of >200 nmol/l after stimulation. Although nebulized steroids seem to be safe in infancy, we recommend that adrenal functions should be tested periodically during long-term treatment with nebulized steroids.


Subject(s)
Androstadienes/administration & dosage , Anti-Asthmatic Agents/administration & dosage , Budesonide/administration & dosage , Hypothalamo-Hypophyseal System/drug effects , Pituitary-Adrenal System/drug effects , Respiratory Sounds/drug effects , Administration, Inhalation , Adrenocorticotropic Hormone/blood , Androstadienes/therapeutic use , Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Asthma/physiopathology , Bronchodilator Agents/administration & dosage , Bronchodilator Agents/therapeutic use , Budesonide/therapeutic use , Child, Preschool , Female , Fluticasone , Humans , Hydrocortisone/blood , Hypothalamo-Hypophyseal System/physiopathology , Infant , Male , Nebulizers and Vaporizers , Pituitary-Adrenal System/physiopathology , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL
...